Literature DB >> 17196637

Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice.

Camron D Bryant1, Kristofer W Roberts, Janet S Byun, Michael S Fanselow, Christopher J Evans.   

Abstract

Morphine analgesic tolerance is heritable in both humans and rodents, with some individuals and strains exhibiting little and others exhibiting robust tolerance. 129S6/SvEv and 129P3/J mice reportedly do not demonstrate tolerance to morphine analgesia. Using our laboratory's standard morphine tolerance regimen and a between-subjects design, tolerance developed in the hot plate and tail withdrawal assays as indicated by a change in analgesic efficacy following a morphine challenge dose. Furthermore, the non-competitive NMDA receptor antagonist MK-801 (dizocilipine) blocked morphine tolerance in 129S6/SvEv and CD-1 mice in the hot plate assay. As previously reported, when a within-subjects design and cumulative dosing was employed, no tolerance was observed in the 129P3/J strain. However, using the same morphine regimen and a between-subjects design, comparable tolerance developed between 129P3/J and C57BL/6J strains following a single challenge dose of morphine. Spontaneous hyperalgesia was observed in the tail withdrawal assay following chronic morphine in C57BL/6J, but not 129P3/J mice. Additionally, morphine-tolerant C57BL/6J mice, but not 129P3/J mice, exhibited a large increase in the frequency of tail flicks during the first second following the baseline nociceptive response which may facilitate detection of the response during the tolerant state. We conclude that the method of tolerance assessment affects the ability to detect tolerance and thus may affect the degree and pattern of heritability of this trait and this could have implications for gene mapping studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196637      PMCID: PMC1905890          DOI: 10.1016/j.pbb.2006.11.012

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  19 in total

1.  Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization.

Authors:  Shoshana Eitan; Camron D Bryant; Nazli Saliminejad; Yu C Yang; Elroy Vojdani; Duane Keith; Roberto Polakiewicz; Christopher J Evans
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

2.  Analgesimetry and ranking of analgesic drugs by the receptacle method.

Authors:  J BEN-BASSAT; E PERETZ; F G SULMAN
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-11-01

3.  Enhanced analgesic potency and reduced tolerance of morphine in 129/SvEv mice: evidence for a deficiency in GM1 ganglioside-regulated excitatory opioid receptor functions.

Authors:  S M Crain; K Shen
Journal:  Brain Res       Date:  2000-02-21       Impact factor: 3.252

4.  Lack of morphine and enkephalin tolerance in 129/SvEv mice: evidence for a NMDA receptor defect.

Authors:  Y Kolesnikov; S Jain; R Wilson; G W Pasternak
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

5.  The effect of cumulative dosing on the analgesic potency of morphine in mice.

Authors:  A Duttaroy; R Kirtman; F Farrell; M Phillips; J Philippe; T Monderson; B C Yoburn
Journal:  Pharmacol Biochem Behav       Date:  1997-09       Impact factor: 3.533

6.  Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat.

Authors:  S Dunbar; T L Yaksh
Journal:  Anesthesiology       Date:  1996-05       Impact factor: 7.892

7.  Opioid and non-opioid stress analgesia: assessment of tolerance and cross-tolerance with morphine.

Authors:  J W Lewis; J E Sherman; J C Liebeskind
Journal:  J Neurosci       Date:  1981-04       Impact factor: 6.167

8.  Chronic pain and genetic background interact and influence opioid analgesia, tolerance, and physical dependence.

Authors:  De-Yong Liang; TianZi Guo; Guochun Liao; Wade S Kingery; Gary Peltz; J David Clark
Journal:  Pain       Date:  2006-03-03       Impact factor: 6.961

9.  The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.

Authors:  Kathryn Elliott; Nobuko Minami; Yuri A Kolesnikov; Gavril W Pasternak; Charles E Inturrisi
Journal:  Pain       Date:  1994-01       Impact factor: 6.961

10.  The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity.

Authors:  Keith A Trujillo
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

View more
  8 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strains.

Authors:  Liang Liu; Janet K Coller; Linda R Watkins; Andrew A Somogyi; Mark R Hutchinson
Journal:  Brain Behav Immun       Date:  2011-04-03       Impact factor: 7.217

3.  Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1.

Authors:  L R Goldberg; S L Kirkpatrick; N Yazdani; K P Luttik; O A Lacki; R K Babbs; D F Jenkins; W E Johnson; C D Bryant
Journal:  Genes Brain Behav       Date:  2017-07-06       Impact factor: 3.449

4.  Role of the guanine nucleotide binding protein, Gαo, in the development of morphine tolerance and dependence.

Authors:  Jennifer T Lamberts; Lisa D Rosenthal; Emily M Jutkiewicz; John R Traynor
Journal:  Psychopharmacology (Berl)       Date:  2017-10-03       Impact factor: 4.530

5.  Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents.

Authors:  Caroline M Kopruszinski; Juliana Swiokla; Yeon Sun Lee; Edita Navratilova; Laurie VanderVeen; Miao Yang; Yi Liu; Takahiro Miyazaki; William K Schmidt; Jonathan Zalevsky; Frank Porreca
Journal:  Cell Mol Neurobiol       Date:  2020-02-27       Impact factor: 5.046

6.  Targeted expression of μ-opioid receptors in a subset of striatal direct-pathway neurons restores opiate reward.

Authors:  Yijun Cui; Sean B Ostlund; Alex S James; Chang Sin Park; Weihong Ge; Kristofer W Roberts; Nitish Mittal; Niall P Murphy; Carlos Cepeda; Brigitte L Kieffer; Michael S Levine; James David Jentsch; Wendy M Walwyn; Yi E Sun; Christopher J Evans; Nigel T Maidment; X William Yang
Journal:  Nat Neurosci       Date:  2014-01-12       Impact factor: 24.884

7.  HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1α/lncRNA BACE1-AS axis.

Authors:  Susmita Sil; Guoku Hu; Ke Liao; Fang Niu; Shannon Callen; Palsamy Periyasamy; Howard S Fox; Shilpa Buch
Journal:  PLoS Biol       Date:  2020-05-26       Impact factor: 8.029

8.  Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids.

Authors:  Douglas J Hermes; Ian R Jacobs; Megan C Key; Alexis F League; Barkha J Yadav-Samudrala; Changqing Xu; Virginia D McLane; Sara R Nass; Wei Jiang; Rick B Meeker; Bogna M Ignatowska-Jankowska; Aron H Lichtman; Zibo Li; Zhanhong Wu; Hong Yuan; Pamela E Knapp; Kurt F Hauser; Sylvia Fitting
Journal:  J Neuroinflammation       Date:  2020-11-18       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.